All News

Investigators find this association primarily affects female patients when compared with male patients.

The FDA removes the prior requirement for a patient who is already diagnosed with a cardiovascular disease.

Palmer addresses the limitations of alternative methods such as acetaminophen, herbal supplements, and cannabis products, urging patients to consult health care professionals.

In association with patients’ race, ethnicity, and social determinants of health, researchers explored the off-label prescribing of GLP-1s approved for type 2 diabetes.

The Signos Glucose Monitoring System uses body signals that help to improve sleep, manage weight, and decrease the risk of chronic disease.

To better understand its potential role in the pharmacy profession, researchers explore artificial intelligence and the ways pharmacists are aware of its growing implementation.

In an exploration of provider reporting and pharmacovigilance, researchers assessed community pharmacists’ knowledge, attitudes, and practices regarding adverse drug reactions.

Chronic pain affects many older adults, highlighting the need for safe acetaminophen use and effective pain management strategies.

Currently, systemic estrogen replacement therapy is contraindicated for women who have a history of ischemic stroke due to the risk of stroke recurrence.

Sustainable CGM counseling combines pharmacist expertise, technician support, multimodal education, and policy advocacy to improve patient outcomes in diabetes care.

New clinical trial results reveal upadacitinib's effectiveness in achieving significant hair regrowth for patients with severe alopecia areata.

Amid increased concerns of vaccine hesitancy among the parents of pediatric patients, researchers sought the most effective communication methods to curb this growing phenomenon.

Simultaneous vaccination with IIV4 and PPSV23 proves safe and effective for patients with chronic diseases, matching results of healthy individuals.

Integrating health-related social needs programs into pharmacy practice strengthens patient care and positions pharmacies as vital public health partners.

Targeted education and hands-on experience are helping pharmacists gain the confidence needed to guide patients in continuous glucose monitoring.

Recent studies reveal that while diabetes technology use rises, glycemic control in type 1 diabetes patients remains low, highlighting significant disparities.

Pharmacies face significant challenges in filling buprenorphine prescriptions for telemedicine patients, impacting opioid use disorder treatment access and patient satisfaction.

Researchers explored the effectiveness of pharmacist-led interventions for improving medication adherence among a group of patients with chronic diseases.

DTC pharmacies offer significant savings on total medication costs for neurological drugs, but out-of-pocket expenses remain high for insured patients.

Despite pharmacists seemingly increasing their distribution of immunization services, vaccine hesitancy and misinformation continue to circulate in various communities.

In the context of the COVID-19 pandemic, researchers investigated how insulin use and glycemic control were associated among patients with type 2 diabetes.

Investigators found that Opill increased access for patients who were uninsured, identified as Black or Latina, had lower education, and lived in the Southern United States.

As continuous glucose monitoring becomes more common, pharmacists are essential in patient education but face barriers of time, training, and reimbursement.

Early planning and strong partnerships enable community pharmacies to manage the surge in vaccines and treatments during flu, COVID-19, and RSV seasons.

Pharmacists leverage socioeconomic insights to combat health disparities, enhancing access to medications and public health services in underserved communities.

Samantha Picking, PharmD, senior director of immunizations at Walgreens, discusses how pharmacists have emerged as the ideal providers to manage vaccine administration.

Amid multiple methods for protecting children against RSV, researchers explored the strengths, limitations, and future approaches of each.

Cyclobenzaprine HCl sublingual tablets (Tonmya) are the first new FDA-approved therapy for fibromyalgia in over 15 years.

FDA approves Wegovy for treating metabolic dysfunction–associated steatohepatitis, marking a breakthrough in liver health management and patient care.

Pharmacists face numerous challenges daily while striving to provide optimal care for their patients.